Miao Zhiming, Ding Jinhua, Chen Bijuan, Yang Yinlong, Chen Yizuo
Department of Breast and Thyroid Surgery, Zhangjiagang Hospital Affiliated to Soochow University, Zhangjiagang Hospital, Jiangsu Province, China -
Minerva Med. 2016 Dec;107(6):392-400. Epub 2016 Jun 22.
HOX transcript antisense intergenic RNA (HOTAIR), a long non-coding RNA transcribed from the antisense strand of the HOXC gene locus, has been reported to be overexpressed in various carcinomas and is thought to be an indicator of poor prognosis.
We performed a meta-analysis using qualified relevant literatures to evaluate the prognostic significance of HOTAIR in various solid tumors. Eligible studies were identified from PubMed, EMBASE and ISI Web of Science through multiple search strategies. We extracted and estimated the hazard ratios (HRs) for overall survival (OS), which compared the high and low expression levels of HOTAIR in patients with a variety of solid carcinomas. HRs and 95% confidence intervals (95% CIs) were calculated to pool the effect size.
A total of 2407 patients from 21 studies with various solid carcinomas were included. For OS, higher HOTAIR expression could significantly predict worse outcome with the pooled HR of 2.21 (95 % CI 1.77-2.74, P<0.00001). The subgroup analysis suggested that the elevated levels of HOTAIR appears to be worse OS in Asian population (HR=2.06, 95% CI 1.80-2.37, P<0.00001) and digestive system cancers (HR=2.27, 95% CI 1.93-2.67, P<0.00001) including esophageal squamous cell carcinoma (HR=2.27, 95% CI 1.62-3.18, P<0.00001) and colorectal cancer (HR=4.65, 95 % CI 2.39-9.05, P<0.00001).
The present meta-analysis revealed that the high level of HOTAIR is associated with an adverse OS in numerous solid cancers, suggesting that HOTAIR may be a predictor of poor prognosis for the development of solid tumors.
HOX转录本反义基因间RNA(HOTAIR)是一种从HOXC基因座反义链转录而来的长链非编码RNA,据报道在多种癌症中过表达,被认为是预后不良的指标。
我们使用符合条件的相关文献进行了一项荟萃分析,以评估HOTAIR在各种实体瘤中的预后意义。通过多种检索策略从PubMed、EMBASE和ISI Web of Science中识别出符合条件的研究。我们提取并估计了总生存期(OS)的风险比(HRs),比较了各种实体癌患者中HOTAIR的高表达水平和低表达水平。计算HRs和95%置信区间(95% CIs)以汇总效应大小。
共纳入了来自21项研究的2407例患有各种实体癌的患者。对于总生存期,HOTAIR表达水平较高可显著预测更差的预后,汇总后的HR为2.21(95% CI 1.77 - 2.74,P < 0.00001)。亚组分析表明,HOTAIR水平升高在亚洲人群(HR = 2.06,95% CI 1.80 - 2.37,P < 0.00001)和消化系统癌症(HR = 2.27,95% CI 1.93 - 2.67,P < 0.00001)包括食管鳞状细胞癌(HR = 2.27,95% CI 1.62 - 3.18,P < 0.00001)和结直肠癌(HR = 4.65,95% CI 2.39 - 9.05,P < 0.00001)中似乎预示着更差的总生存期。
本荟萃分析表明,HOTAIR水平升高与多种实体癌的不良总生存期相关,提示HOTAIR可能是实体瘤发生预后不良的预测指标。